Wells Fargo & Company »

Artiva Biotherapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Artiva Biotherapeutics shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Artiva Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Artiva Biotherapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Artiva Biotherapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $81k 5.3k 15.45

More positions owned by Wells Fargo & Company

Microsoft Corporation (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
JPMorgan Chase & Co. Put Option (JPM)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth (UNH)
Broadcom (AVGO)

View all positions for Wells Fargo & Company

Top funds holding Artiva Biotherapeutics

RA Capital Management
5AM Venture Management
VR Adviser
venBio Partners
Capital World Investors
BlackRock
Franklin Resources
Geode Capital Management
Samsara BioCapital
Woodline Partners
Northern Trust
Citadel Advisors
Alyeska Investment Group
Charles Schwab Investment Management
Bank of New York Mellon

View all funds holding Artiva Biotherapeutics